Williams Anthony, Datar Ram, Cote Richard
Department of Pathology, The University of Miami-Miller School of Medicine, Miami, Florida, USA.
Natl Med J India. 2010 Nov-Dec;23(6):346-50.
Cancer stem cells (CSCs) represent a subclass of tumour cells with the ability for self-renewal, production of differentiated progeny, prolonged survival, resistance to damaging therapeutic agents, and anchorage-independent survival, which together make this population effectively equipped to metastasize, invade and colonize secondary tissues in the face of therapeutic intervention. In recent years, investigators have increasingly focused on the characterization of CSCs to better understand the mechanisms that govern malignant disease progression in an effort to develop more effective, targeted therapeutic agents. The primary obstacle to the study of CSCs, however, is their rarity. Thus, the study of CSCs requires the use of sensitive and efficient technologies for their enrichment and detection. This review discusses technologies and methods that have been adapted and used to isolate and characterize CSCs to date, as well as new potential directions for the enhanced enrichment and detection of CSCs. While the technologies used for CSC enrichment and detection have been useful thus far for their characterization, each approach is not without limitations. Future studies of CSCs will depend on the enhanced sensitivity and specificity of currently available technologies, and the development of novel technologies for increased detection and enrichment of CSCs.
癌症干细胞(CSCs)是肿瘤细胞的一个亚类,具有自我更新能力、产生分化后代的能力、延长生存期、对损伤性治疗药物的抗性以及不依赖锚定的生存能力,这些特性共同使得这群细胞能够在面对治疗干预时有效地转移、侵袭并在继发组织中定植。近年来,研究人员越来越关注癌症干细胞的特性,以更好地理解控制恶性疾病进展的机制,从而努力开发更有效、有针对性的治疗药物。然而,研究癌症干细胞的主要障碍在于其稀有性。因此,对癌症干细胞的研究需要使用灵敏且高效的技术来对其进行富集和检测。本综述讨论了迄今为止已被采用并用于分离和鉴定癌症干细胞的技术和方法,以及增强癌症干细胞富集和检测的新潜在方向。虽然用于癌症干细胞富集和检测的技术目前对其鉴定很有用,但每种方法都有局限性。未来对癌症干细胞的研究将依赖于提高现有技术的灵敏度和特异性,以及开发用于增加癌症干细胞检测和富集的新技术。